Skip to main content
SpringerLink
Log in

Stoffwechsel und Analyse von Leukotrienen in vivo

Metabolism and analysis of leukotrienes in vivo

  • Heinrich-Wieland-Preis-Vorlesung
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Leukotrienes are potent mediators of inflammatory and allergic reactions involved, among others, in endotoxin action and shock, tissue trauma, acute liver injury, hepatorenal syndrome, inflammatory bowel disease, acute pancreatitis, and asthma. Studies on metabolism and analysis of these arachidonate metabolites in vivo are a prerequisite for an improved understanding of their role under physiological and pathophysiological conditions and for the development of inhibitors of leukotriene synthesis and of receptor antagonists. Leukotriene C4 and its metabolites, collectively termed the cysteinyl leukotrienes, are predominantly inactivated by the liver. Rapid hepatocellular uptake is followed by partial metabolic inactivation, comprising ω-oxidation and N-acetylation of leukotriene E4, and excretion into bile. A minor portion of the cysteinyl leukotrienes undergoes enterohepatic circulation. In all species investigated so far, hepatobiliary elimination of cysteinyl leukotrienes predominates over renal excretion.

Analysis of the systemic production of cysteinyl leukotrienes in vivo has been accomplished by radioimmunological determination of species-characteristic index metabolites in bile after their separation by high-performance liquid chromatography. The mercapturate N-acetyl-leukotriene E4 is the index metabolite of choice in the rat. In man, leukotriene E4 is the predominant endogenous cysteinyl leukotriene in both bile and urine. The amounts of cysteinyl leukotrienes detected under various pathophysiological conditions may be sufficient to induce known phenomena associated with the respective disease. As shown under experimental conditions, inhibition of leukotriene synthesis or receptor antagonism can serve as therapeutic approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

HPLC:

High-performance liquid chromatography, Hochleistungsflüssigkeitschromatographie

LT:

Leukotrien

LTC4 :

(S)5-Hydroxy-(R)-6-S-glutathionyl-7,9-trans-11,14-cis-eikosatetraenoat

LTD4 :

(S)5-Hydroxy-(R)-6-S-cysteinylglycyl-7,9-trans-11,14-cis-eikosatetraenoat

LTE4 :

(S)5-Hydroxy-(R)-6-S-cysteinyl-7,9-trans-11,14-cis-eikosatetraenoat

LTE4NAc:

N-Acetyl-LTE4

References

  1. Appelgren LE, Hammarström S (1982) Distribution and metabolism of3H-labeled leukotriene C3 in the mouse. J Biol Chem 257:531–535

    Google Scholar 

  2. Ball HA, Keppler D (1987) ω-Oxidation products of leukotriene E4 in bile and urine of the monkey. Biochem Biophys Res Commun 148:664–670

    Google Scholar 

  3. Baud L, Sraer J, Perez J, Nivez M-P, Ardaillou R (1985) Leukotriene C4 binds to human glomerular epithelial cells and promotes their proliferation in vitro. J Clin Invest 76:374–377

    Google Scholar 

  4. Bernström K, Hammarström S (1986) Metabolism of leukotriene E4 by rat tissues: Formation of N-acetyl-leukotriene E4. Arch Biochem Biophys 244:486–491

    Google Scholar 

  5. Blackwell GJ, Carnuccio R, Di Rosa M, Flower JR, Parente L, Persico P (1980) Macrocortin: A polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature 287:147–149

    Google Scholar 

  6. Brocklehurst WE (1960) The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 151:416–435

    Google Scholar 

  7. Clancy RM, Dahinden CA, Hugli TE (1984) Oxidation of leukotrienes at the ω-end: Demonstration of a receptor for the 20-hydroxy derivatives of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc Natl Acad Sci USA 81:5729–5733

    Google Scholar 

  8. Corey EJ, Clark DA, Marfat A (1984) Structure elucidation and total synthesis of the leukotrienes. Chakrin LW, Bailey MD (eds) The leukotrienes, chemistry and biology. Academic Press, Orlando, pp 13–101

    Google Scholar 

  9. Denzlinger C, Rapp S, Hagmann W, Keppler D (1985) Leukotrienes as mediators in tissue trauma. Science 230:330–332

    Google Scholar 

  10. Denzlinger C, Guhlmann A, Hagmann W, Scheuber PH, Scheyerl F, Wilker D, Hammer DK, Keppler D (1986) Cysteinyl leukotrienes undergo enterohepatic circulation. Prostaglandins Leukotrienes Med 21:321–322

    Google Scholar 

  11. Denzlinger C, Guhlmann A, Scheuber PH, Wikler D, Hammer DK, Keppler D (1986) Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem 261:15601–15606

    Google Scholar 

  12. Di Rosa M, Flower RJ, Hirata F, Parente L, Russo-Marie F (1984) Antiphospholipase proteins. Prostaglandins 28:441–442

    Google Scholar 

  13. Dixon RAF, Jones RE, Diehl RE, Bennett CD, Kargman S, Rouzer CA (1988) Cloning of the cDNA for human 5-lipoxygenase. Proc Natl Acad Sci USA 85:416–420

    Google Scholar 

  14. Dreyling KW, Hoppe U, Peskar BA, Morgenroth K, Kozuschek W, Peskar BM (1986) Leukotriene synthesis by human gastrointestinal tissues. Biochim Biophys Acta 878:184–193

    Google Scholar 

  15. Ezra D, Foster A, Cirino M, Rokach J, Letts LG (1987) Biliary and urinary excretion of peptide leukotrienes in the domestic pig. Prostaglandins 33:717–725

    Google Scholar 

  16. Feldberg W, Kellaway CH (1938) Liberation of histamine and formation of lysolecithin-like substances by cobra venom. J Physiol 94:187–226

    Google Scholar 

  17. Feuerstein G (1985) Autonomic pharmacology of leukotrienes. J Auton Pharmacol 5:149–168

    Google Scholar 

  18. Fitzsimmons BJ, Rokach J (1988) Lipoxygenase inhibitors and leukotriene receptor antagonists. In: Church M, Robinson C (eds) Advances in eicosanoid reserach — eicosanoids in inflammatory conditions of the lung, skin and joints. MTP Press, Lancaster, pp 147–190

    Google Scholar 

  19. Flower RJ, Blackwell GJ (1979) Antiinflammatory steroids induce biosynthesis of a pospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456–459

    Google Scholar 

  20. Ford-Hutchinson AW (1985) Leukotrienes: Their formation and role as inflammatory mediators. Fed Proc 44:25–29

    Google Scholar 

  21. Guhlmann A, Hagmann W, Keppler D (1987) Enterohepatic circulation of N-acetyl-leukotriene E4. Prostaglandins 34:63–70

    Google Scholar 

  22. Hagmann W, Denzlinger C, Keppler D (1984) Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ Shock 14:223–235

    Google Scholar 

  23. Hagmann W, Denzlinger C, Keppler D (1985) Production of peptide leukotrienes in endotoxin shock. FEBS Lett 180:309–313

    Google Scholar 

  24. Hagmann W, Denzlinger C, Rapp S, Weckbecker G, Keppler D (1986) Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. Prostaglandins 31:239–251

    Google Scholar 

  25. Hagmann W, Steffan A-M, Kirn A, Keppler D (1987) Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology 7:732–736

    Google Scholar 

  26. Hagmann W, Keppler D (1988) Leukotrienes and other eicosanoids in liver pathophysiology. In: Arias IM, Jakoby WB, Popper H, Schachter D, and Shafritz DA (eds) The liver: biology and pathobiology. Raven Press, New York, pp 793–806

    Google Scholar 

  27. Hammarström S (1983) Leukotrienes. Annu Rev Biochem 52:355–377

    Google Scholar 

  28. Hammarström S, Örning L, Bernström K (1985) Metabolism of leukotrienes. Mol Cell Biochem 69:7–16

    Google Scholar 

  29. Harper TW, Garrity MJ, Murphy RC (1986) Metabolism of leukotriene B4 in isolated rat hepatocytes. J Biol Chem 261:5414–5418

    Google Scholar 

  30. Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 77:2533–2536

    Google Scholar 

  31. Huber M, Guhlmann A, Jansen PLM, Keppler D (1987a) Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion. Hepatology 7:224–228

    Google Scholar 

  32. Huber M, Kästner S, Schölmerich J, Keppler D (1987b) Enhanced urinary excretion of cysteinyl leukotrienes in patients with hepatorenal syndrome. J Hepatol 5:S34

    Google Scholar 

  33. Huber M, Keppler D (1987) Inhibition of leukotriene D4 catabolism by D-penicillamine. Eur J Biochem 167:73–79

    Google Scholar 

  34. Huber M, Keppler D (1988) Leukotrienes and the mercapturate pathway. In: Sies H, Ketterer B (eds) Glutathione conjugation: its mechanism and biological significance. Academic Press, London, pp 449–470

    Google Scholar 

  35. Jakschik BA, Harper T, Murphy RC (1982) Leukotriene C4 and D4 formation by particulate enzymes. J Biol Chem 257:5346–5349

    Google Scholar 

  36. Keppler A, Örning L, Bernstörm K, Hammarström S (1987) Endogenous leukotriene D4 formation during anaphylactic shock in the guinea pig. Proc Natl Acad Sci USA 84:5903–5907

    Google Scholar 

  37. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK (1985) The relation of leukotrienes to liver injury. Hepatology 5:883–891

    Google Scholar 

  38. Keppler D, Hagmann W, Rapp S (1987) Role of Leukotrienes in endotoxin action in vivo. Rev Inf Diseases 9:S580-S584

    Google Scholar 

  39. Keppler D, Huber M, Weckbecker G, Hagmann W, Denzlinger C, Guhlmann A (1987) Leukotriene C4 metabolism by hepatoma cells and liver. Adv Enzyme Regul 26:211–224

    Google Scholar 

  40. Keppler D, Huber M, Hagmann W, Ball HA, Guhlmann A, Kästner S (1988) Metabolism and analysis of endogenous cysteinyl leukotrienes. Ann NY Acad Sci 524:68–74

    Google Scholar 

  41. Kozak EM, Tate SS (1982) Glutathione-degrading enzymes of microvillus membranes. J Biol Chem 257:6322–6327

    Google Scholar 

  42. Kragballe K, Desjarlais L, Voorhees JJ (1985) Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br J Derm 113:43–52

    Google Scholar 

  43. Lewis RA, Drazen JM, Austen FK, Toda M, Brion F, Marfat A, Corey JE (1981) Contractile activities of structural analogs of leukotrienes C and D: role of the polar substituents. Proc Natl Acad Sci USA 78:4579–4583

    Google Scholar 

  44. Lewis RA, Austen KF (1984) The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest 73:889–897

    Google Scholar 

  45. Matsumoto T, Funk CD, Rådmark O, Höög J-O, Jörnvall H, Samuelsson B (1988) Molecular cloning and amino acid sequence of human 5-lipoxygenase. Proc Natl Acad Sci USA 85:26–30

    Google Scholar 

  46. Murphy RC, Hammarström S, Samuelsson B (1979) Leukotriene C: A slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76:4275–4279

    Google Scholar 

  47. Örning L, Kaijser L, Hammarström S (1985) In vivo metabolism of leukotriene C4 in man: Urinary excretion of leukotriene E4. Biochem Biophys Res Commun 130:214–220

    Google Scholar 

  48. Örning L, Norin E, Gustafsson B, Hammarström S (1986) In vivo metabolism of leukotrine C4 in germ-free and conventional rats. Fecal excretion of N-acetylleukotriene E4. J Biol Chem 261:766–771

    Google Scholar 

  49. Örning L (1987b) ω-Oxidation of cysteine-containing leukotrienes by rat-liver microsomes. Isolation and characterization of ω-hydroxy and ω-carboxy metabolites of leukotriene E4 and N-acetylleukotriene E4. Eur J Biochem 170:77–85

    Google Scholar 

  50. Ormstad K, Uehara N, Orrenius S, Örning L, Hammarström S (1982) Uptake and metabolism of leukotriene C3 by isolated rat organs and cells. Biochem Biophys Res Commun 104:1434–1440

    Google Scholar 

  51. Peskar BM, Dreyling KW, Peskar BA, May B, Goebell H (1986) Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: Inhibition by sulfasalazine and 5-aminosalicylic acid. Agent Actions 18:381–383

    Google Scholar 

  52. Rådmark O, Malmsten C, Samuelsson B (1980) Leukotriene A4: Enzymatic conversion to leukotriene C4. Biochem Biophys Res Commun 96:1679–1687

    Google Scholar 

  53. Rouzer CA, Matsumoto T, Samuelsson B (1986) Single protein from human leukocytes posseses 5-lipoxygenase and leukotriene A4 synthase activities. Proc Natl Acad Sci USA 83:857–861

    Google Scholar 

  54. Samuelsson B (1983) Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 220:568–575

    Google Scholar 

  55. Samuelsson B, Dahlén S-E, Lindgren J-Å, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171–1176

    Google Scholar 

  56. Scheuber PH, Denzlinger C, Wilker D, Beck G, Keppler D, Hammer DK (1987) Cysteinyl leukotrienes as mediators of staphylococcal enterotoxin B in the monkey. Eur J Clin Invest 17:455–459

    Google Scholar 

  57. Söderström M, Hammarström S, Mannervik B (1988) Leukotriene C synthase in murine mastocytoma cells: a novel enzyme distinct from cytosolic and microsomal glutathione transferases. Biochem J 250:713–718

    Google Scholar 

  58. Stene DO, Murphy RC (1988) Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of β-oxidation products of sulfidopeptide leukotrienes. J Biol Chem 263:2773–2778

    Google Scholar 

  59. Uehara N, Ormstad K, Örning L, Hammarström S (1983) Characteristics of the uptake of cysteine-containing leukotrienes by isolated hepatocytes. Biochim Biophys Acta 732:69–74

    Google Scholar 

  60. Weckbecker G, Keppler D (1986) Leukotriene C4 metabolism by hepatoma cells deficient in the uptake of cysteinyl leukotrienes. Eur J Biochem 154:559–562

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deutsches Krebsforschungszentrum, Abteilung Tumorbiochemie, Heidelberg

    D. Keppler

Authors
  1. D. Keppler
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Vortrag anläßlich der Preis-Verleihung am 30. Oktober 1987

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keppler, D. Stoffwechsel und Analyse von Leukotrienen in vivo. Klin Wochenschr 66, 997–1004 (1988). https://doi.org/10.1007/BF01733441

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01733441

Key words

Search

Navigation